Article
[TET2 as a gatekeeper for hematologic malignancies].
[Rinsho ketsueki] The Japanese journal of clinical hematology - 1 Jun 2015
Muto Hideharu, Sakata-Yanagimoto Mamiko, Chiba Shigeru
Abstract excerpt
TET (Ten Eleven Translocation) family proteins are dioxygenases that convert methylcytosine to hydroxymethylcytosine, and play an important role in the DNA demethylation process. Most notably, TET2 mutations have frequently been identified in myeloid malignancies, such as myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN), chronic myelomonocytic leukemia, and acute myeloid leukemias, as well as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
